David Dodd | executive |
Mark Reynolds | executive |
Laura Suriel | analyst |
Kelly McKee | executive |
Jeffrey Kraws | analyst |
Robert LeBoyer | analyst |
John Sharkey | executive |
Jason Kolbert | analyst |
Vernon Bernardino | analyst |
Good afternoon, and welcome, everyone, to the GeoVax Fourth Quarter 2023 Corporate Update Call. My name is Desiree, and I will facilitate today's call.
With me are David Dodd, Chairman and CEO; Mark Reynolds, Chief Financial Officer; Dr. Mark Newman, Chief Scientific Officer; Dr. Kelly McKee, Chief Medical Officer; and Dr.